Related Experiment Video
Updated: May 10, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[Severe coronary artery disease in premenopausal woman with familial hypercholesterolaemia]
Nikolina Roszczyk1, Karina Wierzbowska-Drabik, Radosław Kręcki
1Katedra i Klinika Kardiologii, Uniwersytet Medyczny, Łódź. nikolina_2001@o2.pl
Insights
This case study highlights severe coronary artery disease in a premenopausal woman, primarily driven by familial hypercholesterolemia. Effective management was achieved through comprehensive lipid-lowering therapy.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Familial hypercholesterolemia (FH) is an underdiagnosed genetic disorder leading to premature cardiovascular disease.
- Severe hypercholesterolemia significantly increases the risk of atherosclerosis and acute coronary events.
- Premenopausal women with FH represent a unique patient population requiring specific clinical attention.
Observation:
- A 51-year-old premenopausal woman, a long-term non-smoker, presented with acute coronary syndrome (ACS).
- Severe two-coronary artery disease was diagnosed, with severe hypercholesterolemia identified as the primary risk factor.
- The initial clinical diagnosis of familial hypercholesterolemia was made concurrently with the ACS diagnosis.
Findings:
- The patient's cardiovascular condition was predominantly linked to severe hypercholesterolemia, indicative of familial hypercholesterolemia.
- A multi-faceted lipid-lowering pharmacotherapy regimen was initiated.
- The complex therapeutic approach resulted in a satisfactory reduction in lipid levels.
Implications:
- This case underscores the critical importance of early diagnosis and aggressive management of familial hypercholesterolemia, even in premenopausal women.
- Comprehensive lipid-lowering strategies are effective in managing severe hypercholesterolemia and its cardiovascular consequences.
- Increased awareness and screening for FH are crucial for preventing premature cardiovascular events in at-risk individuals.
Abstract:
We present a case of a 51 year-old, premenopausal, non-smoker for many years woman with severe, two-coronary artery disease in the form of acute coronary syndrome (ACS), and severe hypercholesterolaemia as the predominant risk factor. The first clinical diagnosis of familial hypercholesterolaemia has been established at the time of diagnosis of ACS. Satisfactory effect of pharmacological treatment is achieved by a complex lipid-lowering therapy.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management